title: [Importance of measurement of plasma viral load for the therapeutic follow-up of children infected with HIV-1. Study of its evolution according to modifications of treatment in 55 children].
abstract: Since 1987 we started to treat all vertically HIV-1 infected newborns by an antiretroviral therapy as soon as the diagnosis was confirmed. From the study of 55 HIV-1 infected children followed at Armand Trousseau Hospital (Paris, France) we retrospectively evaluated the use of the plasma viral load as a marker of the treatment efficiency. This parameter and CD4 counts were measured the day of any modification in antiviral therapy (Day 0), 1 and 3 months later (M1 and M3) and every 3 months as long as possible. In the 3 groups of treatment modifications a decrease in plasma viral load was observed. A statistically significant increase in CD4 counts was only observed in the group treated with the association of 2 nucleoside analogues and 1 proteinase inhibitor. This group demonstrated the most important decrease in plasma viral load (> 0.7 log 10 Eq Cop/ml). This leads us to propose to the "ANRS" a protocol study for the treatment of all vertically HIV-1 infected children by the association of 3 nucleoside analogues and 1 proteinase inhibitor as early as 8 weeks post natal when the HIV infection is confirmed.
authors.affiliation: Service d'hématologie et d'oncologie pédiatrique, Hôpital Armand-Trousseau, Paris.
authors.forename: G
authors.initials: G
authors.lastname: Lasfargues
authors.forename: C
authors.initials: C
authors.lastname: Courpotin
authors.forename: J C
authors.initials: JC
authors.lastname: Nicolas
authors.forename: C
authors.initials: C
authors.lastname: Dollfus
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000097:blood / Q000188:drug therapy* / Q000821:virology; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D015497:HIV-1; D006801:Humans; D007223:Infant; D008297:Male; D019562:Viral Load
vernacular_title: Intérêt de la mesure de la charge virale plasmatique pour le suivi thérapeutique des enfants infectés par le VIH1. Etude de son évolution en fonction des modifications du traitement chez 55 enfants.